Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Researchers awarded grant to analyse coughs via mobile phones

This article was originally published in Clinica

Executive Summary

STAR Analytical Services has received a $100,000 grant from the Gates Foundation to develop technology that analyses a patient’s cough via a mobile phone to diagnose pneumonia. The investigators hope that their vocal analysis software, which compares a patient’s cough to a pre-recorded database, could improve healthcare in developing countries, where many people have access to mobile phones but live in remote locations. Identifying whether a cough is caused by a bacterial or viral infection could help the right patients receive antibiotics quickly and halt epidemics, the STAR (Bedford, Massachusetts) researchers hope. They currently have a database of several dozen patients, but estimate they will need around 1,000 for the software to be reliable.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT044729

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel